SHANGHAI -- The World Health Organization on Tuesday approved the second Chinese COVID-19 vaccine for emergency use, providing a possible boost to its global access initiative as concerns about trial data linger.
Sinovac Biotech's CoronaVac joined Sinopharm and five other Western vaccines recognized by the WHO, which is trying to meet the global demand for inoculation.
